Advertisement
UK markets close in 2 hours 21 minutes

  • FTSE 100

    8,114.10
    +35.24 (+0.44%)
     

  • FTSE 250

    19,781.74
    +179.76 (+0.92%)
     

  • AIM

    754.65
    +1.53 (+0.20%)
     

  • GBP/EUR

    1.1672
    +0.0016 (+0.13%)
     

  • GBP/USD

    1.2514
    +0.0003 (+0.03%)
     

  • Bitcoin GBP

    51,237.98
    +790.41 (+1.57%)
     

  • CMC Crypto 200

    1,386.53
    -10.00 (-0.72%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    84.33
    +0.76 (+0.91%)
     

  • GOLD FUTURES

    2,356.40
    +13.90 (+0.59%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,045.48
    +128.20 (+0.72%)
     

  • CAC 40

    8,046.70
    +30.05 (+0.37%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Moderna Gets Good News, but Another Biotech Stock Is Falling Again

Dan Caplinger, The Motley Fool
·3-min read
Moderna Gets Good News, but Another Biotech Stock Is Falling Again

Just as the Nasdaq Composite (NASDAQINDEX: ^IXIC) led markets lower in 2022, the index is working hard to lead a rebound early in 2023. After being the only one of the three major U.S. stock market indexes to finish higher on Tuesday, the Nasdaq once again looked good early Wednesday morning, with futures on the index rising nearly half a percent. One winner leading the Nasdaq higher Wednesday morning was vaccine stock Moderna (NASDAQ: MRNA), which announced positive news that showed investors the company is more than just a one-trick pony.

Continue reading